Posts
Phoenix™ NLME The modern nonlinear mixed effect modeling...
Population PK scientists often encounter barriers when translating conceptual models...
Phoenix WinNonlin™ The industry standard for non-compartmental...
In the fast-paced world of pharmaceutical research, where every day counts in bringing...
Phoenix® IVIVC Toolkit™ Your clear choice for obtaining...
When pharmaceutical companies modify drug formulations or change manufacturing facilities,...
Innovative PBPK software that supports screening, first-in-human...
Revolutionize pre-IND drug development with Simcyp Discovery
Streamline Regulatory Writing with AI-Powered Solutions
Pharmaceutical regulatory writing is a complex, time-intensive process involving...
Streamline Your Regulatory Process with GlobalSubmit eCTD...
In the fast-paced world of pharmaceutical development, regulatory submissions can...
IoT and Remote Patient Monitoring: Transforming Clinical...
Discover how IoT and Remote Patient Monitoring are revolutionizing clinical data...
The Transformative Power of Remote Patient Monitoring in...
Discover how Impakt Care’s RPM platform is transforming healthcare with real-time...
How Impakt Medical's AI-Powered Narrative Intelligence...
Discover how Impakt Medical’s AI-powered platform transforms Medical Affairs in...
AKT Health at BioAsia 2025: Showcasing Innovation in Digital...
At BioAsia 2024, AKT Health made a significant impact by showcasing Impakt Health,...
AKT Health Brings Global Healthcare Innovation to Japan...
Discover the future of Decentralized clinical trials in Boston & Tokyo with thought...
DCTs Quarterly Series Japan 2024: Transforming Clinical...
AKT Health is excited to announce the DCTs Quarterly Series Japan 2024, launching...
Navigating Pharma’s Evolution: Embracing KOLs and DOLs...
The pharmaceutical industry is witnessing a power shift! Traditional KOLs (Key Opinion...
How Decentralized Clinical Trials are Reshaping Medical...
Discover the transformative impact of decentralized clinical trials (DCTs) on clinical...
Navigating Pharma's Evolution: Embracing KOLs and DOLs...
Explore the seismic shift in pharmaceutical marketing as traditional Key Opinion...